ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors.
Essam Ahmed Ghazaly
No relevant relationships to disclose
Ivana Rizzuto
No relevant relationships to disclose
Hani Gabra
No relevant relationships to disclose
Nagy A Habib
No relevant relationships to disclose
Robert C. F. Leonard
No relevant relationships to disclose
Harpreet Wasan
No relevant relationships to disclose
Christopher McGuigan
No relevant relationships to disclose
Sarah Patricia Blagden
No relevant relationships to disclose